JP2014507414A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014507414A5 JP2014507414A5 JP2013549769A JP2013549769A JP2014507414A5 JP 2014507414 A5 JP2014507414 A5 JP 2014507414A5 JP 2013549769 A JP2013549769 A JP 2013549769A JP 2013549769 A JP2013549769 A JP 2013549769A JP 2014507414 A5 JP2014507414 A5 JP 2014507414A5
- Authority
- JP
- Japan
- Prior art keywords
- thiobutoxy
- thiophen
- benzo
- under reduced
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000005309 thioalkoxy group Chemical group 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- -1 1,2-dimethylthiobutoxy Chemical group 0.000 description 2
- SAAWNQLNUJBOLW-UHFFFAOYSA-N 2-(1-benzothiophen-2-yl)acetic acid Chemical compound C1=CC=C2SC(CC(=O)O)=CC2=C1 SAAWNQLNUJBOLW-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000019439 ethyl acetate Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- SPJJYCYYBXUZCP-UHFFFAOYSA-N 2-(1-benzothiophen-2-yl)acetonitrile Chemical compound C1=CC=C2SC(CC#N)=CC2=C1 SPJJYCYYBXUZCP-UHFFFAOYSA-N 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- DEAIGIYAVHOUEQ-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-2-methylazetidine-2-carboxamide Chemical compound C=1C=C(Cl)C=CC=1CNC(=O)C1(C)CCN1 DEAIGIYAVHOUEQ-UHFFFAOYSA-N 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- VKZSTQSXCSNCDH-UHFFFAOYSA-N tert-butyl 2-[(4-chlorophenyl)methylcarbamoyl]-2-methylazetidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC1(C)C(=O)NCC1=CC=C(Cl)C=C1 VKZSTQSXCSNCDH-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161434077P | 2011-01-19 | 2011-01-19 | |
| US61/434,077 | 2011-01-19 | ||
| PCT/EP2012/050297 WO2012098033A1 (en) | 2011-01-19 | 2012-01-10 | Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014507414A JP2014507414A (ja) | 2014-03-27 |
| JP2014507414A5 true JP2014507414A5 (OSRAM) | 2015-03-12 |
Family
ID=45507689
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013549769A Pending JP2014507414A (ja) | 2011-01-19 | 2012-01-10 | 代謝疾患及び炎症疾患の治療に有用なアゼチジン誘導体 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US8759334B2 (OSRAM) |
| EP (1) | EP2665704A1 (OSRAM) |
| JP (1) | JP2014507414A (OSRAM) |
| KR (1) | KR20140040104A (OSRAM) |
| CN (1) | CN103328442A (OSRAM) |
| AR (1) | AR084857A1 (OSRAM) |
| AU (1) | AU2012208693B2 (OSRAM) |
| BR (1) | BR112013018286A2 (OSRAM) |
| CA (1) | CA2824460A1 (OSRAM) |
| CO (1) | CO6741223A2 (OSRAM) |
| GB (1) | GB2489382A (OSRAM) |
| MX (1) | MX2013008257A (OSRAM) |
| PH (1) | PH12013501437A1 (OSRAM) |
| RU (1) | RU2013138372A (OSRAM) |
| SG (1) | SG191291A1 (OSRAM) |
| TW (1) | TW201245144A (OSRAM) |
| WO (1) | WO2012098033A1 (OSRAM) |
| ZA (1) | ZA201304822B (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12013501437A1 (en) * | 2011-01-19 | 2013-09-16 | Galapagos Nv | Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases |
| JP6854126B2 (ja) | 2013-11-27 | 2021-04-07 | エピックス セラピューティクス | 炎症性疾患の治療に使用するための化合物、医薬組成物、および方法 |
| US9839644B2 (en) | 2014-09-09 | 2017-12-12 | ARKAY Therapeutics, LLC | Formulations and methods for treatment of metabolic syndrome |
| KR101656662B1 (ko) * | 2014-11-18 | 2016-09-12 | 한국생명공학연구원 | 2-옥소-1,2,3,4-테트라하이드로피리미딘-5-카르복사미드 유도체를 유효성분으로 함유하는 대사성 질환 예방 또는 치료용 약학적 조성물 |
| HK1251223A1 (en) * | 2015-07-07 | 2019-01-25 | Japan Tobacco, Inc. | Method for producing 7h-pyrrolo[2, 3-d]pyrimidine derivative and intermediate thereof |
| CN110300756B (zh) | 2016-12-21 | 2024-01-02 | 日本烟草产业株式会社 | 7H-吡咯并[2,3-d]嘧啶衍生物的制备方法及其合成中间体 |
| MY196582A (en) | 2018-02-13 | 2023-04-19 | Gilead Sciences Inc | PD-1/PD-L1 Inhibitors |
| WO2019204609A1 (en) | 2018-04-19 | 2019-10-24 | Gilead Sciences, Inc. | Pd-1/pd-l1 inhibitors |
| CN108863980A (zh) * | 2018-07-05 | 2018-11-23 | 浙江工业大学 | 一种合成1-(5-苯并噻唑基)乙酮的方法 |
| PT3820572T (pt) | 2018-07-13 | 2023-11-10 | Gilead Sciences Inc | Inibidores pd-1/pd-l1 |
| EP3870566A1 (en) | 2018-10-24 | 2021-09-01 | Gilead Sciences, Inc. | Pd-1/pd-l1 inhibitors |
| CN110684000B (zh) * | 2019-10-18 | 2021-08-31 | 上海皓元医药股份有限公司 | 苯并呋喃衍生物的制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5927869A (ja) | 1982-08-06 | 1984-02-14 | Sagami Chem Res Center | ４−オキソ−４，５，６，７−テトラヒドロインド−ルの製造方法 |
| CN101023357A (zh) * | 2004-09-22 | 2007-08-22 | 艾尼纳制药公司 | 治疗代谢相关病症的gpr43和其调节剂 |
| EP1888618A4 (en) * | 2005-05-23 | 2009-07-15 | Neuren Pharmaceuticals Ltd | Analogs of glycyl-prolyl-glutamate |
| US20070202515A1 (en) * | 2005-10-12 | 2007-08-30 | Pathologica, Llc. | Promac signature application |
| EP1953238B1 (en) * | 2005-11-04 | 2011-12-21 | Eisai R&D Management Co., Ltd. | Method for screening of substances using GPR40 and secretory phospholipase A2 |
| PE20070978A1 (es) * | 2006-02-14 | 2007-11-15 | Novartis Ag | COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks) |
| WO2008135525A2 (en) * | 2007-05-02 | 2008-11-13 | Boehringer Ingelheim International Gmbh | Substituted azetidines, manufacturing and use thereof as medicaments |
| WO2009104155A1 (en) | 2008-02-21 | 2009-08-27 | Actelion Pharmaceuticals Ltd | 2-aza-bicyclo[2.2.1]heptane derivatives |
| JP2010051307A (ja) * | 2008-07-28 | 2010-03-11 | Eisai R & D Management Co Ltd | Ｔｈ１７細胞およびＴｒｅｇ細胞の分化誘導を調節する物質のスクリーニング方法 |
| PH12013501437A1 (en) * | 2011-01-19 | 2013-09-16 | Galapagos Nv | Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases |
-
2012
- 2012-01-10 PH PH1/2013/501437A patent/PH12013501437A1/en unknown
- 2012-01-10 KR KR1020137020884A patent/KR20140040104A/ko not_active Withdrawn
- 2012-01-10 WO PCT/EP2012/050297 patent/WO2012098033A1/en not_active Ceased
- 2012-01-10 RU RU2013138372/04A patent/RU2013138372A/ru not_active Application Discontinuation
- 2012-01-10 EP EP12700552.8A patent/EP2665704A1/en not_active Withdrawn
- 2012-01-10 CA CA2824460A patent/CA2824460A1/en not_active Abandoned
- 2012-01-10 CN CN2012800059625A patent/CN103328442A/zh active Pending
- 2012-01-10 GB GB1213267.6A patent/GB2489382A/en not_active Withdrawn
- 2012-01-10 MX MX2013008257A patent/MX2013008257A/es not_active Application Discontinuation
- 2012-01-10 US US13/980,798 patent/US8759334B2/en not_active Expired - Fee Related
- 2012-01-10 BR BR112013018286A patent/BR112013018286A2/pt not_active IP Right Cessation
- 2012-01-10 AU AU2012208693A patent/AU2012208693B2/en not_active Expired - Fee Related
- 2012-01-10 JP JP2013549769A patent/JP2014507414A/ja active Pending
- 2012-01-10 SG SG2013048038A patent/SG191291A1/en unknown
- 2012-01-13 AR ARP120100129A patent/AR084857A1/es unknown
- 2012-01-18 TW TW101102008A patent/TW201245144A/zh unknown
-
2013
- 2013-06-27 ZA ZA2013/04822A patent/ZA201304822B/en unknown
- 2013-08-15 CO CO13194671A patent/CO6741223A2/es unknown
-
2014
- 2014-06-23 US US14/311,574 patent/US20140371198A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014507414A5 (OSRAM) | ||
| KR101934096B1 (ko) | 이델라리십의 제조방법 | |
| TWI513691B (zh) | 製備苯并咪唑衍生物之方法 | |
| JP2018529687A5 (OSRAM) | ||
| JP6580218B2 (ja) | エナンチオマー濃縮された３−アミノピペリジンの調製のためのプロセス | |
| JP2014533285A5 (OSRAM) | ||
| JP2013508368A5 (OSRAM) | ||
| CA2914381A1 (en) | An efficient process for separation of diastereomers of 9-[(r)-2-[[(r,s)-[[(s)-1-(isopropoxycarbonyl)ethyl]amino]-phenoxyphosphinyl] methoxy]propyl]adenine | |
| CN103153942A (zh) | 制备叔氨基醇化合物的方法 | |
| HRP20191172T1 (hr) | Proces za proizvodnju aminokiselina iz prekursora dobivenih anaerobnom fermentacijom iz fermentabilne biomase | |
| JP2011520830A5 (OSRAM) | ||
| JP2011513297A5 (OSRAM) | ||
| JP2020502077A5 (OSRAM) | ||
| CN103467304A (zh) | 一种盐酸西那卡塞的制备方法 | |
| JP2011506528A5 (OSRAM) | ||
| CN104703967B (zh) | 氟伏沙明游离碱的精制方法及利用其的高纯度马来酸氟伏沙明的制备方法 | |
| CN108164423B (zh) | 一种盐酸萘替芬的制备方法 | |
| JP2015182974A (ja) | トリエチレンテトラミンの製造方法 | |
| CN105085513A (zh) | 一种制备(r)-3-奎宁环醇的方法 | |
| CN104030938A (zh) | 盐酸丙帕他莫的制备方法 | |
| CN104030942B (zh) | 一种L-α-氨基丁酰胺盐酸盐的制备方法 | |
| CN104086460B (zh) | 2-(甲基氨基)乙基氨基甲酸叔丁酯的合成方法 | |
| JP2012513391A5 (OSRAM) | ||
| KR20080097708A (ko) | 사포그렐레이트 염산염의 제조방법 | |
| RU2741389C1 (ru) | Способ получения промежуточного соединения для синтеза лекарственного средства |